CAREDX, INC. Research and Development Expense
CAREDX, INC. (CDNA) reported Research and Development Expense of $22.38 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-07-30
- CAREDX, INC. research and development expense for the quarter ending 2026-06-30 was $22.38M, a 32.95% increase year-over-year.
- CAREDX, INC. research and development expense for the quarter ending 2026-03-31 was $21.42M, a 15.61% increase year-over-year.
- CAREDX, INC. research and development expense for the quarter ending 2025-12-31 was $19.31M, a 16.16% increase year-over-year.
- CAREDX, INC. research and development expense for the quarter ending 2025-09-30 was $16.77M, a 4.10% decline year-over-year.
- CAREDX, INC. research and development expense for fiscal 2025 was $71.43M, a 1.49% decline from fiscal 2024.
- CAREDX, INC. research and development expense for fiscal 2024 was $72.51M, a 12.02% decline from fiscal 2023.
- CAREDX, INC. research and development expense for fiscal 2023 was $82.42M, a 8.81% decline from fiscal 2022.
- CAREDX, INC. research and development expense for fiscal 2022 was $90.39M, a 18.12% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $22.38M 10-Q · filed 2026-07-30 | $43.79M 10-Q · filed 2026-07-30 | $63.10M derived: sum of 3 quarters · filed 2026-07-30 | $79.87M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $21.42M 10-Q · filed 2026-04-28 | $40.72M derived: sum of 2 quarters · filed 2026-04-28 | $57.49M derived: sum of 3 quarters · filed 2026-04-28 | $74.32M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $19.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $36.08M derived: sum of 2 quarters · filed 2026-02-25 | $52.91M derived: sum of 3 quarters · filed 2026-07-30 | $71.43M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $16.77M 10-Q · filed 2025-11-04 | $33.60M derived: sum of 2 quarters · filed 2026-07-30 | $52.12M 10-Q · filed 2025-11-04 | $68.74M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $16.83M 10-Q · filed 2026-07-30 | $35.35M 10-Q · filed 2026-07-30 | $51.97M derived: sum of 3 quarters · filed 2026-07-30 | $69.46M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $18.52M 10-Q · filed 2026-04-28 | $35.14M derived: sum of 2 quarters · filed 2026-04-28 | $52.63M derived: sum of 3 quarters · filed 2026-04-28 | $72.32M derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2024-12-31 | $16.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $34.11M derived: sum of 2 quarters · filed 2026-02-25 | $53.80M derived: sum of 3 quarters · filed 2026-02-25 | $72.51M 10-K · filed 2026-02-25 | $72.41M 10-K · filed 2025-02-28 | |||
| 2024-09-30 | $17.49M 10-Q · filed 2025-11-04 | $37.18M derived: sum of 2 quarters · filed 2025-11-04 | $55.89M 10-Q · filed 2025-11-04 | $55.88M 10-Q · filed 2024-11-04 | $74.72M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2024-06-30 | $19.69M 10-Q · filed 2025-08-06 | $19.68M 10-Q · filed 2024-07-31 | $38.40M 10-Q · filed 2025-08-06 | $38.39M 10-Q · filed 2024-07-31 | $57.23M derived: sum of 3 quarters · filed 2026-02-25 | $76.23M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | $18.71M 10-Q · filed 2025-04-30 | $37.54M derived: sum of 2 quarters · filed 2026-02-25 | $56.54M derived: sum of 3 quarters · filed 2026-02-25 | $76.78M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | $18.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $37.83M derived: sum of 2 quarters · filed 2026-02-25 | $58.06M derived: sum of 3 quarters · filed 2026-02-25 | $82.42M 10-K · filed 2026-02-25 | $81.87M 10-K · filed 2024-02-28 | |||
| 2023-09-30 | $19.00M 10-Q · filed 2024-11-04 | $39.23M derived: sum of 2 quarters · filed 2024-11-04 | $63.59M 10-Q · filed 2024-11-04 | $87.16M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $20.23M 10-Q · filed 2024-07-31 | $44.59M 10-Q · filed 2024-07-31 | $68.16M derived: sum of 3 quarters · filed 2025-02-28 | $90.47M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | $24.36M 10-Q · filed 2024-05-09 | $47.93M derived: sum of 2 quarters · filed 2025-02-28 | $70.23M derived: sum of 3 quarters · filed 2025-02-28 | $92.86M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $23.57M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $45.88M derived: sum of 2 quarters · filed 2025-02-28 | $68.51M derived: sum of 3 quarters · filed 2025-02-28 | $90.39M 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | $22.31M 10-Q · filed 2023-11-08 | $44.94M derived: sum of 2 quarters · filed 2023-11-08 | $66.82M 10-Q · filed 2023-11-08 | $88.86M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | $22.63M 10-Q · filed 2023-08-08 | $44.51M 10-Q · filed 2023-08-08 | $66.56M derived: sum of 3 quarters · filed 2024-02-28 | $86.00M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | $21.88M 10-Q · filed 2023-05-10 | $43.93M derived: sum of 2 quarters · filed 2024-02-28 | $63.37M derived: sum of 3 quarters · filed 2024-02-28 | $82.40M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | $22.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $41.48M derived: sum of 2 quarters · filed 2024-02-28 | $60.52M derived: sum of 3 quarters · filed 2024-02-28 | $76.53M 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | $19.44M 10-Q · filed 2022-11-03 | $38.48M derived: sum of 2 quarters · filed 2022-11-03 | $54.48M 10-Q · filed 2022-11-03 | $67.80M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | $19.04M 10-Q · filed 2022-08-04 | $35.04M 10-Q · filed 2022-08-04 | $48.37M derived: sum of 3 quarters · filed 2023-02-27 | $60.84M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | $16.00M 10-Q · filed 2022-05-05 | $29.33M derived: sum of 2 quarters · filed 2023-02-27 | $41.80M derived: sum of 3 quarters · filed 2023-02-27 | $54.93M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | $13.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $25.80M derived: sum of 2 quarters · filed 2023-02-27 | $38.93M derived: sum of 3 quarters · filed 2023-02-27 | $48.94M 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | $12.47M 10-Q · filed 2021-10-28 | $25.60M derived: sum of 2 quarters · filed 2021-10-28 | $35.62M 10-Q · filed 2021-10-28 | $44.56M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $13.13M 10-Q · filed 2021-07-29 | $23.14M 10-Q · filed 2021-07-29 | $32.09M derived: sum of 3 quarters · filed 2022-02-24 | $40.61M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $10.01M 10-Q · filed 2021-05-05 | $18.96M derived: sum of 2 quarters · filed 2022-02-24 | $27.48M derived: sum of 3 quarters · filed 2022-02-24 | $35.11M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $8.95M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $17.47M derived: sum of 2 quarters · filed 2022-02-24 | $25.10M derived: sum of 3 quarters · filed 2022-02-24 | $30.71M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $8.52M 10-Q · filed 2020-10-29 | $16.15M derived: sum of 2 quarters · filed 2020-10-29 | $21.77M 10-Q · filed 2020-10-29 | $25.55M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | $7.63M 10-Q · filed 2020-08-04 | $13.24M 10-Q · filed 2020-08-04 | $17.03M derived: sum of 3 quarters · filed 2021-02-24 | $20.89M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | $5.61M 10-Q · filed 2020-04-30 | $9.40M derived: sum of 2 quarters · filed 2021-02-24 | $13.26M derived: sum of 3 quarters · filed 2021-02-24 | $16.76M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | $3.78M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $7.65M derived: sum of 2 quarters · filed 2021-02-24 | $11.15M derived: sum of 3 quarters · filed 2021-02-24 | $14.51M 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | $3.87M 10-Q · filed 2019-10-31 | $7.36M derived: sum of 2 quarters · filed 2019-10-31 | $10.73M 10-Q · filed 2019-10-31 | $13.76M derived: sum of 4 quarters · filed 2020-02-28 | ||||
| 2018-06-30 | $3.50M 10-Q · filed 2019-08-01 | $6.86M 10-Q · filed 2019-08-01 | $9.89M derived: sum of 3 quarters · filed 2020-02-28 | $12.85M derived: sum of 4 quarters · filed 2020-02-28 | ||||
| 2018-03-31 | $3.37M 10-Q · filed 2019-05-08 | $6.40M derived: sum of 2 quarters · filed 2020-02-28 | $9.36M derived: sum of 3 quarters · filed 2020-02-28 | $12.47M derived: sum of 4 quarters · filed 2020-02-28 | ||||
| 2017-12-31 | $3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $5.99M derived: sum of 2 quarters · filed 2020-02-28 | $9.11M derived: sum of 3 quarters · filed 2020-02-28 | $12.39M 10-K · filed 2020-02-28 | ||||
| 2017-09-30 | $2.96M 10-Q · filed 2018-11-08 | $6.08M derived: sum of 2 quarters · filed 2018-11-08 | $9.36M 10-Q · filed 2018-11-08 | $12.51M derived: sum of 4 quarters · filed 2019-03-06 | ||||
| 2017-06-30 | $3.12M 10-Q · filed 2018-08-09 | $6.40M 10-Q · filed 2018-08-09 | $9.55M derived: sum of 3 quarters · filed 2019-03-06 | $12.48M derived: sum of 4 quarters · filed 2019-03-06 | ||||
| 2017-03-31 | $3.28M 10-Q · filed 2018-05-10 | $6.44M derived: sum of 2 quarters · filed 2019-03-06 | $9.37M derived: sum of 3 quarters · filed 2019-03-06 | $12.51M derived: sum of 4 quarters · filed 2019-03-06 | ||||
| 2016-12-31 | $3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $6.08M derived: sum of 2 quarters · filed 2019-03-06 | $9.23M derived: sum of 3 quarters · filed 2019-03-06 | $12.38M 10-K · filed 2019-03-06 | ||||
| 2016-09-30 | $2.93M 10-Q · filed 2017-11-09 | $6.07M derived: sum of 2 quarters · filed 2017-11-09 | $9.23M 10-Q · filed 2017-11-09 | $11.94M derived: sum of 4 quarters · filed 2018-03-22 | ||||
| 2016-06-30 | $3.14M 10-Q · filed 2017-08-11 | $6.30M 10-Q · filed 2017-08-11 | $9.01M derived: sum of 3 quarters · filed 2018-03-22 | $11.70M derived: sum of 4 quarters · filed 2018-03-22 | ||||
| 2016-03-31 | $3.16M 10-Q · filed 2017-06-09 | $5.86M derived: sum of 2 quarters · filed 2018-03-22 | $8.56M derived: sum of 3 quarters · filed 2018-03-22 | $11.07M derived: sum of 4 quarters · filed 2018-03-22 | ||||
| 2015-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $5.40M derived: sum of 2 quarters · filed 2018-03-22 | $7.91M derived: sum of 3 quarters · filed 2018-03-22 | $9.33M 10-K · filed 2018-03-22 | ||||
| 2015-09-30 | $2.70M 10-Q · filed 2016-11-14 | $5.21M derived: sum of 2 quarters · filed 2016-11-14 | $6.63M 10-Q · filed 2016-11-14 | $7.93M derived: sum of 4 quarters · filed 2017-04-21 | ||||
| 2015-06-30 | $2.51M 10-Q · filed 2016-08-22 | $3.93M 10-Q · filed 2016-08-22 | $5.23M derived: sum of 3 quarters · filed 2017-04-21 | $6.26M derived: sum of 4 quarters · filed 2017-04-21 | ||||
| 2015-03-31 | $1.42M 10-Q · filed 2016-05-16 | $2.72M derived: sum of 2 quarters · filed 2017-04-21 | $3.75M derived: sum of 3 quarters · filed 2017-04-21 | $4.55M derived: sum of 4 quarters · filed 2017-04-21 | ||||
| 2014-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-21 | $2.33M derived: sum of 2 quarters · filed 2017-04-21 | $3.13M derived: sum of 3 quarters · filed 2017-04-21 | $3.85M 10-K · filed 2017-04-21 | ||||
| 2014-09-30 | $1.04M 10-Q · filed 2015-11-13 | $1.83M derived: sum of 2 quarters · filed 2015-11-13 | $2.55M 10-Q · filed 2015-11-13 | $3.21M derived: sum of 4 quarters · filed 2016-03-29 | ||||
| 2014-06-30 | $792.00K 10-Q · filed 2015-08-12 | $1.51M 10-Q · filed 2015-08-12 | $2.17M derived: sum of 3 quarters · filed 2016-03-29 | $2.84M derived: sum of 4 quarters · filed 2016-03-29 | ||||
| 2014-03-31 | $720.00K 10-Q · filed 2015-05-14 | $1.38M derived: sum of 2 quarters · filed 2016-03-29 | $2.05M derived: sum of 3 quarters · filed 2016-03-29 | $2.89M derived: sum of 4 quarters · filed 2016-03-29 | ||||
| 2013-12-31 | $660.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $1.33M derived: sum of 2 quarters · filed 2016-03-29 | $2.17M derived: sum of 3 quarters · filed 2016-03-29 | $3.18M 10-K · filed 2016-03-29 | ||||
| 2013-09-30 | $668.00K 10-Q · filed 2014-11-14 | $1.51M derived: sum of 2 quarters · filed 2014-11-14 | $2.52M 10-Q · filed 2014-11-14 | |||||
| 2013-06-30 | $846.00K 10-Q · filed 2014-08-28 | $1.85M 10-Q · filed 2014-08-28 | ||||||
| 2012-12-31 | $4.75M 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |